Considerations for Clinical Trial Sites

In this article with Ophthalmology Management, Lexitas Chief Medical Officer, David Tanzer, MD, ABO, and Operational Strategy Director, Yesha Raval, share insights into the key metrics that sponsors and CROs use to evaluate and select ophthalmic clinical trial sites.

Key selection criteria discussed:

– Infrastructure and communication

– Patient population and referral network

– Operational performance and historical data

– Team expertise as it relates to the needs of the study

Our Visionary Insights newsletter is published once a month and has thousands of subscribers. To stay in touch, subscribe today.